Πλοήγηση ανά Συγγραφέα "Dalekos, G. N."

Adipokines as mediators of endothelial function and atherosclerosis

Ntaios, G.; Gatselis, N. K.; Makaritsis, K.; Dalekos, G. N. (2013)

For many decades, adipose tissue was considered as an inactive body compartment that was only used as an energy store. During the recent years, an increasing amount of data has revealed that adipose tissue is a major ...

Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease

Gatselis, N. K.; Ntaios, G.; Makaritsis, K.; Dalekos, G. N. (2014)

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and can progress to cirrhosis, liver failure, and hepatocellular carcinoma. In the last two decades, the prevalence of NAFLD has ...

Adiponectin: A New Independent Predictor of Liver Steatosis and Response to IFN-alpha Treatment in Chronic Hepatitis C

Zografos, T. A.; Liaskos, C.; Rigopoulou, E. I.; Togousidis, E.; Makaritsis, K.; Germenis, A.; Dalekos, G. N. (2008)

OBJECTIVES: To compare serum adiponectin and tumor necrosis factor (TNF)-alpha among patients with viral liver diseases; to investigate associations of serum adiponectin and TNF-alpha with histological or viral characteristics ...

Advanced intrahepatic cholangiocarcinoma in hepatitis C virus-related decompensated cirrhosis: case report and review of the literature

Polizos, A.; Kelekis, N.; Sinani, C.; Patsiaoura, K.; Papadamou, G.; Dalekos, G. N. (2003)

A 75-year-old man with no known previous liver disease was admitted to our institution because of right pleural effusion, backache, and pain in the upper right quadrant. Physical and laboratory work-up revealed decompensated ...

Alpha-actinin: A multidisciplinary protein with important role in B-cell driven autoimmunity

Kikonomou, K. G.; Zachou, K.; Dalekos, G. N. (2011)

Alpha-actinin (α-actinin) is a ubiquitous cytoskeletal protein, which belongs to the superfamily of filamentous actin (F-actin) crosslinking proteins. It is present in multiple subcellular regions of both muscle and ...

Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis

Zografos, T. A.; Rigopoulou, E. I.; Liaskos, C.; Togousidis, E.; Zachou, K.; Gatselis, N.; Germenis, A.; Dalekos, G. N. (2006)

Background/Aims: Leptin has a particular profibrogenic role in the liver. We investigated whether IFN-alpha influences leptin production in patients with chronic hepatitis B (CHB) and C (CHC). Leptin was determined in ...

Anti-a actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1

Zachou, K.; Oikonomou, K.; Renaudineau, Y.; Chauveau, A.; Gatselis, N.; Youinou, P.; Dalekos, G. N. (2012)

Background We reported that combined presence of autoantibodies (Abs) against filamentous-actin (AFA) and a-actinin are specific for autoimmune hepatitis type 1 (AIH-1) diagnosis. Aim To explore our data and assess whether ...

ANTI-alpha ACTININ ANTIBODIES ARE INDEPENDENT PREDICTORS OF RESPONSE TO TREATMENT IN AUTOIMMUNE HEPATITIS TYPE 1

Zachou, K.; Renaudineau, Y.; Chauveau, A.; Youinou, P.; Dalekos, G. N. (2010)

Anti-alpha-actinin antibodies cross-react with Anti-ssDNA antibodies in active autoimmune hepatitis

Renaudineau, Y.; Dalekos, G. N.; Gueguen, P.; Zachou, K.; Youinou, P. (2008)

Recently, we have observed that the association of anti-F-actin autoantibodies (Abs) with anti-alpha-actinin Abs (double reactivity) was correlated with liver disease activity in autoimmune hepatitis type 1 (AIH-1; Gueguen ...

Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome

Zachou, K.; Liaskos, C.; Christodoulou, D. K.; Kardasi, M.; Papadamou, G.; Gatselis, N.; Georgiadou, S. P.; Tsianos, E. V.; Dalekos, G. N. (2003)

Background Although controversial, some authorities have implicated hepatitis C virus (HCV) as a cause of anti-phospholipid syndrome (APLS). Anti-cardiolipin antibodies (anti-CLAbs) in APLS are cofactor-dependent ('pathogenic' ...

Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis

Bogdanos, D. P.; Liaskos, C.; Pares, A.; Norman, G.; Rigopoulou, E. I.; Caballeria, L.; Dalekos, G. N.; Rodes, J.; Vergani, D. (2007)

Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-alpha 2a treatment

Mederacke, I.; Yurdaydin, C.; Dalekos, G. N.; Bremer, B.; Erhardt, A.; Cakaloglu, Y.; Yalcin, K.; Gurel, S.; Zeuzem, S.; Zachou, K.; Bozkaya, H.; Dienes, H. P.; Manns, M. P.; Wedemeyer, H.; Hep-Net Int Delta Hepatitis, Study (2012)

Background: The role of anti-HDV immunoglobulin M (IgM) testing in patients receiving pegylated interferon-alpha therapy for hepatitis delta is unknown. We performed anti-HDV IgM testing in a well defined cohort of HDVinfected ...

ANTI-HELICOBACTER PYLORI ANTIBODY RESPONSE AS A TRIGGER OF PRIMARY BILIARY CIRRHOSIS-SPECIFIC ANTI-MITOCHONDRIAL ANTIBODIES

Koutsoumpas, A.; Polymeros, D.; Liaskos, C.; Mytilinaiou, M.; Dalekos, G. N.; Bogdanos, D. P.; Vergani, D. (2008)

Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies

Koutsoumpas, A.; Mytilinaiou, M.; Polymeros, D.; Dalekos, G. N.; Bogdanos, D. P. (2009)

Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: Revealing the unforeseen

Bogdanos, D. P.; Liaskos, C.; Rigopoulou, E. I.; Dalekos, G. N. (2006)

Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis

Rigopoulou, E. I.; Bogdanos, D. P.; Liaskos, C.; Koutsoumpas, A.; Baum, H.; Vergani, D.; Dalekos, G. N. (2007)

Background: Primary biliary cirrhosis (PBC)-specific anti-mitochondrial antibodies (AMA), routinely detected by indirect immunofluoresnce, immunofix various mitochondrial antigens by immunoblot (IB). We have investigated ...

Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis

Zachou, K.; Gampeta, S.; Gatselis, N. K.; Oikonomou, K.; Goulis, J.; Manoussakis, M. N.; Renaudineau, Y.; Bogdanos, D. P.; Dalekos, G. N. (2015)

Background & AimsAntibodies (Abs) to soluble liver antigen/liver pancreas (anti-SLA/LP) are considered markers of worse prognosis and outcome in patients with autoimmune hepatitis (AIH) although this assumption has recently ...

Anti-sp100 antibodies in primary biliary cirrhosis

Rigopoulou, E. I.; Dalekos, G. N. (2004)

Antibody responses specific for soluble liver antigen co-occur with RO-52 autoantibodies in patients with autoimmune hepatitis

Liaskos, C.; Bogdanos, D. P.; Rigopoulou, E. I.; Norman, G. L.; Shurns, Z.; Al-Chalabi, T.; Krawitt, E. L.; Mieli-Vergani, G.; Czaja, A. J.; Vergani, D.; Dalekos, G. N. (2007)

Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis

Rigopoulou, E. I.; Davies, E. T.; Bogdanos, D. P.; Liaskos, C.; Mytilinaiou, M.; Koukoulis, G. K.; Dalekos, G. N.; Vergani, D. (2007)

Background/Aims: Primary biliary cirrhosis (PBC) is characterised by the presence of immunoglobulin (Ig) G antimitochondrial antibodies (AMA), which are routinely detected by indirect immunofluorescence (IFL) using composite ...